Get the Stockscreener App
48.53
1.06%
0.51
After Hours:
48.53
Amphastar Pharmaceuticals Inc stock is traded at $48.53, with a volume of 256.35K.
It is up +1.06% in the last 24 hours and down -0.43% over the past month.
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
See More
Previous Close:
$48.02
Open:
$48.06
24h Volume:
256.35K
Relative Volume:
0.66
Market Cap:
$2.37B
Revenue:
$712.89M
Net Income/Loss:
$166.52M
P/E Ratio:
24.89
EPS:
1.95
Net Cash Flow:
$178.13M
1W Performance:
-0.16%
1M Performance:
-0.43%
6M Performance:
+10.52%
1Y Performance:
+5.52%
1-Day Range:
$48.00
$49.22
1-Week Range:
$46.58
$49.22
52-Week Range:
$36.56
$65.92
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Name
Amphastar Pharmaceuticals Inc
Sector
Phone
909-980-9484
Address
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-17-23 | Initiated | BofA Securities | Neutral |
| Jul-25-23 | Resumed | Jefferies | Buy |
| Oct-21-22 | Resumed | Jefferies | Buy |
| Jul-29-22 | Initiated | CapitalOne | Overweight |
| Jan-07-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jan-08-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-05-20 | Upgrade | Northland Capital | Market Perform → Outperform |
| May-01-20 | Initiated | Northland Capital | Outperform |
| Mar-13-19 | Downgrade | Needham | Buy → Hold |
| Mar-13-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-10-18 | Reiterated | Needham | Buy |
| Mar-13-18 | Reiterated | Needham | Buy |
| Dec-01-17 | Reiterated | Needham | Buy |
| Nov-09-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Sep-27-17 | Reiterated | Needham | Buy |
| Mar-14-17 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-09-16 | Reiterated | Needham | Buy |
| May-10-16 | Reiterated | Needham | Buy |
| Feb-19-16 | Initiated | Wells Fargo | Outperform |
| Jun-19-15 | Reiterated | Needham | Buy |
| Jun-03-15 | Initiated | Raymond James | Strong Buy |
| Jul-21-14 | Initiated | Needham | Buy |
View All
Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News
Deerfield Management Company L.P. Series C Takes $265,000 Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Point72 DIFC Ltd Has $85,000 Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Bought by Public Sector Pension Investment Board - Defense World
Where are the Opportunities in (AMPH) - Stock Traders Daily
Intech Investment Management LLC Invests $426,000 in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Hancock Whitney Corp Has $230,000 Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Naloxone Market: Projected to Witness Growth and Trends - openPR
Hsbc Holdings PLC Sells 226,786 Shares of Amcor plc (NYSE:AMCR) - MarketBeat
Amplitude, Inc. (NASDAQ:AMPL) Shares Bought by Rhumbline Advisers - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Epoch Investment Partners Inc. - MarketBeat
It would be worthwhile to take a closer look at Apollomics Inc (APLM) - US Post News
Investor’s Toolkit: Key Ratios for Assessing Apollomics Inc (APLM)’s Performance - The Dwinnex
There is no doubt that Amplitude Inc (AMPL) ticks all the boxes. - SETE News
Lombard Odier Asset Management USA Corp Acquires Shares of 38,627 Amplitude, Inc. (NASDAQ:AMPL) - Defense World
GILD: 3 Biotech Stocks to Watch as FDA Approvals Roll In - StockNews.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Purchased by Epoch Investment Partners Inc. - Defense World
Inspire Investing LLC Grows Position in Amplitude, Inc. (NASDAQ:AMPL) - Defense World
Mutual of America Capital Management LLC Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
América Móvil, S.A.B. de C.V. (NYSE:AMX) Shares Sold by Dalton Investments Inc. - Defense World
Amplitude, Inc. (NASDAQ:AMPL) Shares Bought by MQS Management LLC - Defense World
América Móvil, S.A.B. de C.V. (NYSE:AMX) Shares Sold by Dalton Investments Inc. - MarketBeat
Renaissance Technologies LLC Sells 61,400 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Avalon Global Asset Management LLC Boosts Stake in Lululemon Athletica Inc. (NASDAQ:LULU) - Defense World
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Holdings Lowered by Renaissance Technologies LLC - Defense World
Granite Investment Partners LLC Increases Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Granite Investment Partners LLC Raises Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals (NASDAQ:AMPH) Upgraded by StockNews.com to Buy - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Increased to Buy at StockNews.com - Defense World
Top investors say Amphastar Pharmaceuticals Inc (AMPH) ticks everything they need - SETE News
Amphastar Pharmaceuticals (NASDAQ:AMPH) jumps 10% this week, though earnings growth is still tracking behind three-year shareholder returns - Yahoo Finance
American Century Companies Inc. Purchases 121,764 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
American Century Companies Inc. Purchases 121,764 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amplitude, Inc. (NASDAQ:AMPL) Shares Acquired by Arizona State Retirement System - Defense World
Texas Permanent School Fund Corp Boosts Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Arizona State Retirement System Purchases 410 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Objective long/short (AMPH) Report - Stock Traders Daily
Rhumbline Advisers Raises Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
U.S. Naloxone Market Projected to See Significant Growth from - openPR
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by Victory Capital Management Inc. - MarketBeat
Quest Partners LLC Buys 4,348 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Victory Capital Management Inc. Has $7.88 Million Stock Position in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Investors Continue Waiting On Sidelines For Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Simply Wall St
Federated Hermes Inc. Sells 132,301 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Lowered to Hold at StockNews.com - Defense World
Director Petersen Floyd F. sale 3,000 shares of Amphastar Pharmaceuticals Inc [AMPH] - Knox Daily
Amphastar Pharmaceuticals Offers Interesting Growth And Income Prospects (NASDAQ:AMPH) - Seeking Alpha
Amphastar: Perplexing Pipeline, Lumpy RevenuesI'm On Sidelines (NASDAQ:AMPH) - Seeking Alpha
LSV Asset Management Cuts Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Shares Sold by LSV Asset Management - Defense World
Bank of New York Mellon Corp Sells 4,529 Shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Zurcher Kantonalbank Zurich Cantonalbank Reduces Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World
Amphastar Pharmaceuticals Inc Stock (AMPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.23%
0.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):